Literature DB >> 12628985

Interferon-gamma reduces interleukin-4- and interleukin-13-augmented transforming growth factor-beta2 production in human bronchial epithelial cells by targeting Smads.

Fu-Qiang Wen1, Xiangde D Liu, Yusuke Terasaki, Qiuhong H Fang, Tetsu Kobayashi, Shinji Abe, Stephen I Rennard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12628985

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  Natural killer T cells are dispensable in the development of allergen-induced airway hyperresponsiveness, inflammation and remodelling in a mouse model of chronic asthma.

Authors:  Y-I Koh; J-U Shim; J-H Lee; I-J Chung; J-J Min; J H Rhee; H C Lee; D H Chung; J-O Wi
Journal:  Clin Exp Immunol       Date:  2010-04-29       Impact factor: 4.330

Review 2.  Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.

Authors:  Bashar S Staitieh; Elisabetta A Renzoni; Srihari Veeraraghavan
Journal:  Ann Med       Date:  2015-01-22       Impact factor: 4.709

Review 3.  Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma.

Authors:  Jing Zhang; Yuan Zou; Longmin Chen; Qianqian Xu; Yi Wang; Min Xie; Xiansheng Liu; Jianping Zhao; Cong-Yi Wang
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

4.  IL-13 induces a bronchial epithelial phenotype that is profibrotic.

Authors:  Nikita K Malavia; Justin D Mih; Christopher B Raub; Bao T Dinh; Steven C George
Journal:  Respir Res       Date:  2008-03-18

Review 5.  Airway Remodeling in Asthma.

Authors:  Kenneth P Hough; Miranda L Curtiss; Trevor J Blain; Rui-Ming Liu; Jennifer Trevor; Jessy S Deshane; Victor J Thannickal
Journal:  Front Med (Lausanne)       Date:  2020-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.